Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
Aether Industries Limited

Aether Industries Limited

NSE: AETHER
Specialty ChemicalsBasic MaterialsMID CAPMCap ₹20.42k Cr
₹1,538.60₹-57.00 (-3.57%)

Market Closed • NSE

Market cap₹20.42k Cr
Enterprise value₹21.44k Cr
P/E TTM86.63
Forward P/E52.05
P/B8.31
EPS TTM₹17.76
Forward EPS₹29.56
ROCE11.90%
D/E0.19
Dividend yield0.00%
Face value₹10.00
52W high₹1,814.10
52W low₹728.00
Price chart(1Y)
1Y Return:+34.62% (+₹395.70)
H: ₹1,814.1L: ₹1,135
1W-13.53%
1M-5.22%
3M+6.13%
6M+30.24%
1Y+106.38%
Today at a glance

Day range

₹1,521.20₹1,606.00

52 week range

₹728.00₹1,814.10
Volume499.4K1.28x 20D avg
Free float50.00%+28.50% volume

Aether Industries Limited closed at INR1538.60 (-3.57%) on volume 1.28x its 20-day average, trading 15.19% below its 52-week high.

Technical analysis
RSI (14)36.5Neutral (30–70)
MACDBEARISHBearish (Below signal)
ATR (14)₹71.64High
SMA 20₹1,694.27BEARISH
SMA 50₹1,659.44BEARISH
SMA 100₹1,498.24BULLISH
SMA 200₹1,279.48BULLISH
CPR bottom₹1,634.00
Pivot₹1,621.20
CPR top₹1,608.40
What changed recently?

2026-Q2

Q2 FY2026 Financial Results

PAT moved +16.7% QoQ

Shariah audit
Methodology: AAOIFI Shariah Standard No. 21
PASS4/4 criteria
Shariah Compliant
CriteriaNumeratorDenominatorValueThresholdStatus
Interest-bearing debt ratio₹458.0 Cr₹20.42k Cr2.24%≤ 33%PASS
Non-halal income ratio–₹1.16k Cr0.00%≤ 5%PASS
Illiquid assets ratio–₹3.20k Cr—≥ 20%PASS
Receivables ratio–₹3.20k Cr—≤ 49%PASS
Valuation & sector context
MetricCompanySector
P/E86.6321.90
Forward P/E52.05—
P/B8.312.20
EV/EBITDA58.9018.00
PEG—1.00
Earnings yield1.204.60
Growth & profitability
RevenuePAT
FY26PAT margin 18.90%

Revenue and PAT bars use independent scales to make their year-on-year direction readable.

Revenue CAGR 3Y0.00%
Revenue CAGR 5Y0.00%
PAT CAGR 3Y-0.10%
PAT CAGR 5Y0.00%
Operating margin24.91%
Net margin19.12%
Financial health & cash flow
Net debt₹458.0 CrHealthy
Interest coverage20.20xEBIT / interest
CFO / PAT0.65x3Y average
Net debt / EBITDA1.26xLeverage
Operating cash flow₹142.0 Cr
Capital expenditure–
Free cash flow₹142.0 Cr
Financial statements

Complete reported financial history · Values use the company's reporting currency

Hover over the chart for exact reported values. Percentage lines use the right-hand axis.

Fundamental scorecard
Overall65/100
Valuation35/100
Profitability65/100
Financial health95/100

A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.

Strengths, risks & investment thesis

Strengths

Low Debt Profile: Debt-to-Equity is comfortable at 0.19x

Risks

Stretched Valuation: Trading at a high P/E multiple of 86.6x

Bull case

Market Leadership: Established operational scale in Specialty Chemicals.

Bear case

Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.

Flip condition

Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.

Shareholding pattern
Quarterly ownership historyLatest valid period · September 2024

Ownership distribution

Sept 2024Latest holding

Category trends

Hover over a period for exact holdings

80%53%27%0%Sept 2024
17.91%Institutional holding
7.17%Public holding
1Periods available
0.00%Promoter pledged
65.34KShareholders
Delivery participation

Traded volume and delivery percentage across the latest 20 sessions

Average delivery (20D)43.22%+3.96% latest vs average
Highest delivery57.37%on 01 Oct
Average volume (20D)388.7KTrading-session average
Conviction trendStrengthening+3.96% latest reading
Traded volumeDelivery %
Peer comparison

Compare valuation, latest quarterly performance and year-on-year growth

8 companies
Company nameMarket cap ₹ CrP/E ratioDividend yield %Quarterly sales ₹ CrProfit after tax ₹ CrSales growth %Profit growth %
UltraTech Cement Limited
UltraTech Cement LimitedULTRACEMCO
Open analysis
₹3.21L37.592.21%₹25,799.47₹2,982.76+11.86%+20.17%
JSW Steel Limited
JSW Steel LimitedJSWSTEEL
Open analysis
₹2.97L12.050.59%₹47,364.00₹4,651.00+11.55%+112.96%
Hindustan Zinc Limited
Hindustan Zinc LimitedHINDZINC
Open analysis
₹2.28L13.372.07%₹13,687.00₹5,425.00+77.22%+146.14%
Asian Paints Limited
Asian Paints LimitedASIANPAINT
Open analysis
₹2.24L46.941.17%₹10,541.94₹1,539.25+17.94%+39.96%
Tata Steel Limited
Tata Steel LimitedTATASTEEL
Open analysis
₹2.19L19.832.27%₹60,794.00₹2,385.00+14.32%+18.83%
Hindalco Industries Limited
Hindalco Industries LimitedHINDALCO
Open analysis
₹2.02L12.320.56%₹84,825.00₹7,013.00+32.06%+75.15%
Grasim Industries Limited
Grasim Industries LimitedGRASIM
Open analysis
₹1.98L34.820.35%₹11,794.71₹246.65-70.60%-82.61%
Solar Industries India Limited
Solar Industries India LimitedSOLARINDS
Open analysis
₹1.81L90.930.06%₹3,668.00₹666.00+70.29%+88.67%
About Aether Industries Limited
Aether Industries Limited

Incorporated in 2013, Aether Industries Limited is a manufacturer of specialty chemicals. The company is sole Indian manufacturer for chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), and 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone, and Bifenthrin Alcohol.[1]

IndiaBasic Materials

Questions investors ask
Is Aether Industries Limited Shariah compliant?

Aether Industries Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (2.24%) complies with AAOIFI threshold (≤ 33%).

What is Aether Industries Limited's current valuation relative to peers?

Aether Industries Limited trades at a P/E of 86.6x compared to the sector median of 21.9x, and a Price-to-Book of 8.3x.

Is the company financially healthy?

The company has a Debt-to-Equity ratio of 0.19x and a Net Debt to EBITDA ratio of 1.26x. Interest coverage is 20.2x.

What are the historical revenue and profit growth rates?

Over the past 5 years, revenue compounded at 0% while net profit growth averaged 0%.

Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.

Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.